“Sivelestat sodium attenuates acute lung injury by inhibiting JNK/NF-κB and activating Nrf2/HO-1 signaling pathways ” (2023) Biomolecules and Biomedicine, 23(3), pp. 457–470. doi:10.17305/bb.2022.8549.